One of the biggest drug companies, GSK, has been chastised by a Senate Committee for hiding information from the public about Avandia causing an increased risk of cardiovascular disease. The report claims that GSK also tried to intimidate a scientist from submitting an article to that effect that was eventually published in the New England Journal of Medicine. At least 7 major drug companies have paid a total of $7 billion in fines since 2004 for such “unseemly activity”. Despite this cost of doing business, these companies continue to make huge profits in a troubled economy.
See Family Practice News (click here), 3/15/10, p. 5.